Stefan Störk is an expert in Cardiology at University Hospital Würzburg (Germany). As of October 2026, ScienceLeadR ranks Stefan Störk in the top 1% of experts worldwide for Heart Failure and Epidemiologic Studies. Stefan Störk has authored 702 publications, the most recent in 2026, and is an investigator in 33 clinical trials, 5 of them ongoing. SLR score: 2,649 (community average: 125). How the SLR is computed.

LeadR Profile

Stefan Störk University Hospital Würzburg Germany
2 649 ScienceLeadR Reputation 2649
Network Map

Cardiology

Subspecialties: Public Health - Medical Imaging - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2011 - 2026

Source: PubMed

University Hospital Würzburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 702

Citations

Citations: 25 895 1st author: 38 Last author: 105 Unique author: 69


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.
PMID 42706896 — hospitalization, heart failure, heart failure, systolic, therapeutics
Eur J Heart Fail20260
EUROASPIRE 1996-2026: 30 years of research into prevention of cardiovascular disease.
PMID 42669129 — cardiovascular diseases, secondary prevention, surveys and questionnaires, research
Eur J Prev Cardiol20260
Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States.
PMID 42667611 — digitoxin, heart failure, probability, heart, heart failure, systolic, quality-adjusted life years, european union
Eur J Heart Fail20261
Efficacy of digitoxin over time in patients with heart failure and reduced ejection fraction: further analysis of DIGIT-HF.
PMID 42667604 — digitoxin, heart failure, heart
Eur J Heart Fail20261
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.
PMID 42666091 — heart diseases, heart, cardiac rehabilitation, rehabilitation, cardiology, secondary prevention, coronary disease, risk factors
Eur Heart J Top journal20261

Clinical Studies 33

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 15
N/A 14
Phase 2 4

By status:

Completed 20
Recruiting 6
Active not recruiting 3
Terminated 2
Not yet recruiting 1
Unknown 1

By type:

Interventional 26
Observational 7

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 2
multicentric5to9 0
multicentricup10 20

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity
2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research
Phase 3Recruiting2026
The RAPID Elapse study Can the drug bupropion improve fatigue symptoms in patients with long COVID
2025-524443-12-00 — bupropion, pharmaceutical preparations, signs and symptoms, covid-19, fatigue, therapeutics, post-acute covid-19 syndrome
Phase 2Not yet recruiting2026
A study to determine if ALXN2220 is effective safe and tolerable in adults with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
2023-506669-70-00 — safety, prealbumin, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis
Phase 3Active not recruiting2024
Perioperative Interdisciplinary Intersectoral Process Optimization in Heart Failure
NCT06381427 — nurses, heart failure, heart, postoperative care, decision making, perioperative care, physicians, anesthesiologists, cardiologists, physicians, primary care, surgeons
N/ARecruiting2024
The Application of Virtual Reality Exposure Versus Relaxation Training in Music Performance Anxiety
NCT05735860 — virtual reality, muscles, blood, stress, physiological, autogenic training, hearing, aftercare, muscle relaxation, signs and symptoms, virtual reality exposure therapy, anxiety disorders, therapeutics, performance anxiety
N/ARecruiting2022

LeadR Networks

Main global connection map